Plain-English translation of NCT06026436 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research is developing two specialized blood tests to measure your individual risk of blood clots or bleeding after a heart procedure. If you have moderate kidney disease and have had a recent heart attack, these tests may help doctors personalize your blood-thinning medication to keep you safer. The study involves 850 patients and aims to create an automated way to measure these risk markers.
Patients with kidney disease who have heart attacks face a difficult balance: they need blood-thinning medication to prevent clots, but kidney disease makes them more likely to bleed. This study exists to find a better way to predict individual risk so doctors can tailor treatment to each patient's needs.
You likely qualify if…
You likely don't qualify if…
You will provide at a hospital with a heart catheterization lab, either when you arrive for your heart procedure or shortly after. The research team will test your blood using the new blood tests to measure your clotting and bleeding risk markers. Your participation is observational—you are not taking a new medication, just allowing researchers to study your blood to help develop better risk prediction tools.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
France